Previous 10 | Next 10 |
2024-02-05 11:04:56 ET Summary DocGo has recently faced a series of negative events, including criticism from the NY Times, Comptroller contract rejection, CEO departure on false CV allegations, and a short report. Despite these challenges, the company presented strong Q3 2023 res...
DocGo Inc . (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in February and March: BTIG at Snowbird – The 11 th Annual BTIG MedTech, Digital Health, Life...
2024-01-31 13:14:50 ET A New York-based healthcare company is turning heads on Wednesday after it was announced that the company had received board approval to repurchase up to $36 million of its common stock through July 30. As you very well may know, this is the opposite of a dilutive...
2024-01-31 10:00:03 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...
2024-01-31 07:58:34 ET More on DocGo DocGo: Growth Significantly Exceeded My Expectations DocGo Inc. (DCGO) Q3 2023 Earnings Call Transcript Biggest stock movers today: Hertz Global, Crypto-linked stocks, Southwestern Energy, and more DocGo releases response ...
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that its Board of Directors has approved a new share repurchase program pursuant to which DocGo may purchase up to $36 million of its ...
As previously disclosed in our press release dated January 10, 2024, DocGo Inc. (“DocGo” or the “Company”) categorically rejects “Fuzzy Panda Research’s” (FP) January 10 th assessment of DocGo’s business practices. As we previously advis...
2024-01-12 15:00:30 ET More on the markets S&P 500: Traders Buy, Investors Sell Recession Forecasting - The Business Cycle Back To 1928 (Part 2) 2024 Analyst Outlook: Victor Dergunov On Undervalued Sectors Uncovering New Year Opportunities Investors were ...
San Francisco, California--(Newsfile Corp. - January 12, 2024) - Hagens Berman urges DocGo Inc. (NASDAQ: DCGO) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/dcgo Contact An Attorney Now: DCGO@hbsslaw.com 844-916-089...
2024-01-11 05:15:42 ET Related stock stories: Marathon Digital: Poised To Ride The Bullish Bitcoin Wave In 2024 Coinbase: Why This Exchange Is A Better Investment Than Buying Cryptocurrencies Marathon Digital Holdings: Overhyped And Overbought SEC at long las...
News, Short Squeeze, Breakout and More Instantly...
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial resul...
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has launched emergency medical and 911 services in Dover, Delaware. This press release features multim...
The partnership expands DocGo’s ability to support patients and vulnerable populations DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced its partnership with Spect, a ...